Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
28-Nov-2023 | |||
Efficacy and safety of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis and dipss low/intermediate-1 risk myelofibrosis: updated results and genomic characteristics (oral presentation) Proceeding/Conference:European Hematology Association Annual Congress 2023 (08/06/2023-15/06/2023, Frankfurt) | 10-Jun-2023 | ||
28-Nov-2023 |